Cite

HARVARD Citation

    Lim, Y. et al. (2022). Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data. Alimentary pharmacology & therapeutics. 55 (8), pp. 921-943. [Online]. 
  
Back to record